We consider the regulation of Pip4k2c, Ehmt2, Gper1, Dicer 1, Cul4b, Fyco1, Gn3l and TNNT2 in the context of doxorubicin-induced cardiomyopathy as particularly relevant. The gene discussed is GPER1; the disease is cardiomyopathy.